APA (7th ed.) Citation

Albash, R., El-Dahmy, R. M., Hamed, M. I. A., Darwish, K. M., Alahdal, A. M., Kassem, A. B., & Fahmy, A. M. (2022). Repurposing levocetirizine hydrochloride loaded into cationic ceramide/phospholipid composite (CCPCs) for management of alopecia: Central composite design optimization, in-silico and in-vivo studies. Drug Delivery, 29(1), 2784. https://doi.org/10.1080/10717544.2022.2108939

Chicago Style (17th ed.) Citation

Albash, Rofida, Rania Moataz El-Dahmy, Mohammed I. A. Hamed, Khaled M. Darwish, Abdulrahman M. Alahdal, Amira B. Kassem, and Abdurrahman M. Fahmy. "Repurposing Levocetirizine Hydrochloride Loaded into Cationic Ceramide/phospholipid Composite (CCPCs) for Management of Alopecia: Central Composite Design Optimization, In-silico and In-vivo Studies." Drug Delivery 29, no. 1 (2022): 2784. https://doi.org/10.1080/10717544.2022.2108939.

MLA (9th ed.) Citation

Albash, Rofida, et al. "Repurposing Levocetirizine Hydrochloride Loaded into Cationic Ceramide/phospholipid Composite (CCPCs) for Management of Alopecia: Central Composite Design Optimization, In-silico and In-vivo Studies." Drug Delivery, vol. 29, no. 1, 2022, p. 2784, https://doi.org/10.1080/10717544.2022.2108939.